Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/24/2025
Starna Thera Raises $44M in Series B to Advance RNA-Based Therapies
10/24/2025
Boehringer Ingelheim's Jascayd Wins NMPA Approval for IPF
10/24/2025
Terns Halts Development of TERN-601 After Phase 2 Results
10/24/2025
Biokin Passes HKEX Hearing, Poised for Hong Kong Listing
10/24/2025
METiS's AI-Designed MTS-004 Becomes China's First AI-Enabled Formulati...
10/24/2025
Chinese Biotech Launches Genos, an Advanced Human-Centric Genomic AI M...
10/24/2025
China NMPA Publishes 97th Batch of Reference Formulations for Generic...
10/22/2025
Innovent and Takeda Ink $11.4B Oncology Alliance
10/22/2025
Samsung Bioepis and Phrontline Forge Partnership to Co-Develop Next-Ge...
10/22/2025
China's Aging Population to Drive Trillion-Dollar Healthcare Boom, UBS...
10/22/2025
Multitude Reports Strong Efficacy for CD44v9-Targeted ADC AMT-116 at E...
10/22/2025
Zai Lab Launches First Phase 3 Trial of DLL3-Targeted ADC ZL-1310 in R...
10/22/2025
GenScript Wins NMPA IND Nod for Bispecific ADC GenSci139
10/22/2025
Understanding China's Longevity Market: Industry Segments, Trends and ...
10/21/2025
ESMO 2025 Highlights China's Strategic Leap in Oncology Innovation
10/21/2025
Merck KGaA and Abbisko Report Strong Phase 3 Results for Pimicotinib a...
10/21/2025
RemeGen's Disitamab Vedotin Plus Toripalimab Delivers Breakthru First-...
10/21/2025
Sunnovo Invests in Byterna to Advance Circular mRNA
10/21/2025
Riltide Completes Seed Financing to Advance AI-Driven Autoimmune Thera...
10/21/2025
Kelun-Biotech’s Sacituzumab Tirumotecan Shows Strong Phase 3 Results
10/21/2025
CSPC's JSKN003 Granted Breakthru Therapy Designation in China
10/21/2025
Henlius' PD-L1 ADC HLX43 Receives Orphan Drug Designation in the U.S.
10/20/2025
Akeso Reports Strong China Data for Ivonescimab in Lung Cancer
10/20/2025
Sanofi Launches €1B Insulin API Manufacturing Project in Beijing
10/20/2025
CDE Seeks Comments on Implementation Recommendations and Chinese Tran...
10/20/2025
CDE Solicits Comments on the Reference Formulations for Chemical Gener...
10/20/2025
CDE Seeks Feedbacks on Draft Technical and Submission Requirements for...
10/20/2025
China Accelerates Nationwide Rollout of Real-Time BMI Fund Settlement
10/20/2025
Kelun Gains China Approval for First Homegrown HER2 Breast Cancer ADC
10/17/2025
I-Mab to Rebrand as NovaBridge Biosciences and Pursue Hong Kong IPO
Page:
2
/
797
Total number of articles:
23885
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit